Patients predisposed to blood clots present genetic markers

Oct 06, 2010

UCD researchers jointly led by Conway Fellow, Dr. Patricia Maguire and Professor Des Fitzgerald, Professor of Molecular Medicine & Vice-President for Research, have identified new genes that contribute to platelet function and promote blood clot formation. Their findings are described recently in a leading haematology journal, Blood.

This collaborative research is a significant advance for the Bloodomics consortium, a European wide effort by scientists to uncover genetic markers that can identify those people most at risk of clot formation and heart attacks.

Platelets are small blood cells that circulate in the bloodstream until they are called into action. When activated, platelets trigger a sequence of events that cause a blood clot to form. This is a normal response when a blood vessel is damaged but, when a blood clot forms as part of a stroke or heart attack, it can deprive the heart muscle of vital oxygen.

Unravelling the genetic roots of atherothrombosis and cardiovascular disease will enable better screening for those most at risk of these diseases and offer targeted therapeutic interventions.

The research carried out in UCD Conway Institute initially identified 63 genes linked to a variation in platelet response. The team carried out further investigation on six of these genes and were able to show that two resulting proteins in particular, commd7 and lrrfip1, have a significant role in regulating thrombus formation.

Commenting on the work, Dr. Maguire said, “By tracing the cellular network and understanding the function of the proteins involved in the platelet response, we want to provide new insight into the causes of . This work is a substantial step towards our goal of developing novel platelet inhibitors that can lower the morbidity and mortality associated with these prevalent diseases."

Maguire and her team also published significant work last year in the Proceedings of the National Academy of Sciences describing a novel platelet signalling network that dampens function. They believe that this signalling pathway may not be correctly regulated in heart disease formation and its discovery is an important development to find new drugs in the fight against heart disease. Dr Brian Steele, the first author on that manuscript, won a prestigious young investigator award at the 2009 International Society of Thrombosis and Haemostasis meeting in Boston for his work on this subject.

Explore further: Recombinant peptide for transplantation of pancreatic islets in mice models of diabetes

More information: Maguire and her team also published significant work last year in the Proceedings of the National Academy of Sciences describing a novel platelet signalling network that dampens platelet function.

Provided by University of Dublin

not rated yet
add to favorites email to friend print save as pdf

Related Stories

How life-threatening blood clots take hold

Apr 16, 2009

When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press public ...

New clot-buster found

Jan 20, 2009

( -- Exciting research into blood clotting by British Heart Foundation (BHF) researchers working at the University of Bristol will take us a step closer to better heart attack prevention and treatment. ...

Genetic septet in control of blood platelet clotting

Jun 22, 2010

In what is believed to be the largest review of the human genetic code to determine why some people's blood platelets are more likely to clump faster than others, scientists at Johns Hopkins and in Boston have found a septet ...

Study points to potential new use for Viagra

Aug 26, 2008

A "basic science" breakthrough by Queen's University researchers into regulating a single enzyme may lead to new drug therapies that will help prevent heart attacks and strokes.

Recommended for you

Novel nanoparticle therapy promotes wound healing

Mar 26, 2015

An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.